Henk Marquering (Netherlands)

Amsterdam UMC, location AMC Biomedical Engineering

Author Of 3 Presentations

BEYOND ETICI 2B REPERFUSION: VALUE OF ADDITIONAL PASSES TO ACHIEVE COMPLETE REPERFUSION

Session Type
Free Communication Session
Date
29.10.2021, Friday
Session Time
15:15 - 16:45
Room
FREE COMMUNICATIONS A
Lecture Time
15:35 - 15:45

Abstract

Background and Aims

Currently, it is unclear whether during endovascular treatment (EVT) for acute ischemic stroke, an extra pass should be undertaken to achieve more complete reperfusion after expanded Treatment In Cerebral Ischemia (eTICI) 2B is already achieved. We aimed to compare outcomes of single-pass good reperfusion (eTICI 2B) with multi-pass (near-)complete reperfusion (eTICI 2C-3) in daily clinical practice.

Methods

We included MR CLEAN Registry patients with M1 occlusions in whom EVT was ended either after achieving eTICI 2B in a single pass or after achieving eTICI 2C/3 in multiple passes. Regression models were used to investigate the association between single-pass eTICI 2B versus multi-pass eTICI 2C/3 with 24-hour National Institutes of Health Stroke Scale (NIHSS) score and 90-day functional outcome (modified Rankin Scale [mRS]).

Results

In 114 (28%) patients, eTICI 2B was achieved after a single pass; in 292 (72%) patients eTICI2C/3 was achieved after multiple passes. Patients with single-pass eTICI 2B showed lower 24-hour NIHSS scores (-19% [95% CI -33 to -1%]) and better functional outcomes (acOR 1.32 [95 % CI 0.93-1.87]) than patients with eTICI 2C/3 after ≥3 passes (Figure 1). No significant difference in functional outcomes was found between single-pass eTICI 2B and eTICI 2C/3 in two passes.

figure 1.jpg

Conclusions

Our results do not provide arguments to continue an EVT procedure when eTICI 2B is reached after one pass, but further research is necessary to investigate the per-pass effect in relation to reperfusion and functional outcome.

Hide

ASSOCIATION OF THROMBUS DENSITY IN PATIENTS WITH M1 OCCLUSIONS WITH OUTCOME

Session Type
Free Communication Session
Date
29.10.2021, Friday
Session Time
17:15 - 18:45
Room
FREE COMMUNICATIONS A
Lecture Time
17:45 - 17:55

Abstract

Background and Aims

The association of thrombus density with reperfusion and functional outcome remains conflicted in acute ischemic stroke. We evaluated if hyperdense thrombi were associated with reperfusion and functional outcome after endovascular treatment (EVT).

Methods

Thrombus imaging characteristics were measured in patients with M1 occlusions included in the MR CLEAN Registry. Thrombus density was measured on thin-slice (<2.5 mm) non-contrast computed tomography. Based on median density across the dataset, hyperdense thrombi were defined as thrombi >50 Hounsfield Units (HU). Regression models were used to investigate the association between hyperdense thrombi, successful reperfusion (expanded Treatment In Cerebral Ischemia (eTICI) score 2B-3), and favorable and excellent functional outcome (modified Rankin Scale (mRS) of 0-2 and 0-1, respectively) at 90 days. We adjusted for age, gender, baseline National Institutes of Health Stroke Scale, prestroke mRS, clot burden score, intravenous alteplase treatment (IVT) and carotid tandem lesions. Subgroup analyses were performed in patients treated with or without IVT prior to EVT.

Results

In 434 analyzed patients, hyperdense thrombi were not associated with successful reperfusion (aOR 0.99 [95%CI 0.65-1.51]) or favorable functional outcome (aOR 1.28 [95%CI 0.81-2.01]). Hyperdense thrombi were inversely associated with excellent functional outcome (aOR 0.52 [95%CI 0.32-0.85]). This association was stronger in patients treated with IVT prior to EVT (aOR 0.47 [95%CI 0.26-0.85]) than in EVT only patients (aOR 0.85 [95%CI 0.29-2.52]) (Figure 1).

figure 1_new.jpg

Conclusions

Hyperdense thrombi were not significantly associated with reperfusion or favorable functional outcome. However, patients with hyperdense thrombi less often achieved excellent functional outcome after EVT.

Hide

ASSOCIATION BETWEEN THROMBUS CHARACTERISTICS, SUCCESSFUL REPERFUSION AND FUNCTIONAL OUTCOME AFTER ENDOVASCULAR TREATMENT IN PATIENTS WITH POSTERIOR CIRCULATION STROKE.

Session Type
Oral Presentations
Date
27.10.2021, Wednesday
Session Time
07:00 - 07:30
Room
ORAL PRESENTATIONS 2
Lecture Time
07:00 - 07:10

Abstract

Background and Aims

Thrombus perviousness and length are important thrombus imaging characteristics related to outcome in patients with anterior circulation ischemic stroke. We investigated the association of thrombus characteristics with reperfusion and functional outcome in patients with posterior circulation stroke (PCS) who underwent endovascular treatment (EVT).

Methods

Thrombus imaging characteristics (perviousness, density, and length) were measured in patients with PCS registered in the MR CLEAN Registry between 2014-2018. All characteristics were assessed on thin-slice (<2.5mm) non-contrast computed tomography and computed tomography angiography imaging acquired within 30 minutes from each other. We compared thrombus characteristics in patients with or without excellent reperfusion (expanded Treatment In Cerebral Ischemia (eTICI) score ≥2C) and with or without favorable functional outcome (modified Rankin Scale score (mRS) 0-3) using the Mann-Whitney U-test.

Results

Sixty-six patients were analyzed. Median thrombus perviousness was 7 (IQR -1-21) Hounsfield Units (HU). Median density was 54 (IQR 44-66) HU and median length was 24 (IQR 15-42) mm. No significant between-group differences were found in thrombus characteristics (Table 1).

eTICI<2C (n=32)

eTICI≥2C (n=29)

p value

mRS 0-3 (n=27)

mRS 4-6 (n=37)

p value

Thrombus imaging characteristics

Length (mm), median (IQR)

24 (14-49)

21 (15-29)

0.45

21 (15-29)

25 (15-48)

0.24

Perviousness (HU), median (IQR)

11 (1-21)

7 (-4-18)

0.42

2 (-2-20)

10 (1-21)

0.29

Density (HU), median (IQR)

55 (47-66)

51 (43-62)

0.63

55 (43-66)

50 (44-65)

0.64

Conclusions

In this study of patients with PCS treated with EVT, thrombus imaging characteristics were not associated with reperfusion or functional outcome.

Hide